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20 K Elder, MH JohnsonIntroduction
Louise Joy Brown was born on 25 July 1978, an event that has
had a major impact on science, medicine and society
(Franklin, 2013). In the two preceding papers, we reported
on our analysis of research notes spanning 1969 to 1978
covering the period when Edwards, Steptoe and Purdy were
working in Oldham and Cambridge towards this achievement
(Elder and Johnson, 2015a), and on the numbers
of treatment cycles involved and their outcomes (Elder
and Johnson, 2015b). In this paper, we consider the
evidence relating to variations in key aspects of the
procedures that Edwards, Steptoe and Purdy attempted in
order to overcome the numerous technical, scientific,
practical and logistical challenges they faced. An overview
of some of the many problems that had to be addressed and
overcome (Edwards and Steptoe, 1974) is presented in
Table 1. We present a historical perspective on the steps
taken to resolve these issues. The data for this report
are taken primarily from the two sets of notebooks, L0–L9
and H1-H4, H7-H9, as described in Elder and Johnson
(2015a), supplemented with additional material from the
Edwards’ archive, which are referenced as RGE1, 2 etc.,
followed by the date.
Results and discussion
Laparoscopic oocyte recovery procedure: follicle
aspiration, ovulation induction and timing
Having realized that in-vitro matured oocytes were not
competent to develop as embryos, preliminary attempts at
laparoscopic oocyte recovery (LOR) may have already
commenced late in 1968, as mentioned in Edwards and
Steptoe’s 1980 account in their volume A Matter of Life
(Edwards and Steptoe, 1980, pp.80–81) and reported in
Edwards et al. (1969, p.635; published on 15 February,
submitted December, 1968). During 1969 the main emphasis
was on improving the timing and technique of laparoscopy
and recovery of eggs after triggering oocyte maturation.
Follicles were initially aspirated using a syringe and needle,Table 1 Some of challenges that had to be overcome before
the first successful live birth following IVF and embryo transfer
was achieved.
Challenge
Technical aspects of follicle aspiration (‘new suction gadget’)
Ovulation induction
Timing of laparoscopy
Ovarian stimulation
Cycle monitoring
Oocyte culture
Sperm preparation
Insemination procedure: medium, timing
Culture for embryo cleavage: medium, assessment
Technical aspects of embryo transfer, including route of
transfer, medium and timing
Luteal supportbut this method was found to be unsatisfactory (Steptoe and
Edwards, 1970). In September 1969 a “new suction gadget –
boiled” was introduced (Figure 1), which had a bypass valve
that allowed the assistant to control suction, with the result
that clearer follicular fluids could be collected. This ‘gadget’
was then used with variations in suction pressure of 1, 4, 5, 8,
10, 12 cm Hg, before establishing an ‘optimum’ pressure of no
greater than 12 cm Hg, 'since higher pressures may damage
the oocytes' (Edwards et al., 1980b; Steptoe and Edwards,
1970, p.684).
Initially, human chorionic gonadotrophin (HCG; Pregnyl,
Organon) was administered in order to induce final follicular
maturation when an adequate concentration of urinary
oestrogens was detected in 24-hour samples (N75 μg/day),
usually on day 11 or 12 of the cycle. Although guided by the
timing of oocyte maturation in vitro (Edwards, 1965), schedul-
ing the laparoscopy was determined mainly by the team’s
availability and their access to the operating theatre: “HCGwas
given at an arbitrary time, selected for our own purposes and
not because the patient had been fully primed by the HMG”
(Steptoe and Edwards, 1970). The dataset for 1969 records that
HCG was administered 29–31 hours prior to laparoscopy (See
Table 2 and Suppl. Table in Elder and Johnson, 2015b).
Doses of HCG were initially related to the dose of
gonadotropin administered for inducing follicular matura-
tion, and varied from 3000 to 12,000 IU (Table 1; Steptoe
and Edwards, 1970), 5000 IU being adopted from September
1969 onwards, when “a regimen of three injections of HMG
between days 2 and 9, and 5000 IU of HCG on days 9–11 of the
menstrual cycle gave the best response” (Steptoe and Edwards,
1970). The interval between HCG and egg collection was also
varied, and the duration of this interval was compared with the
presence of corpora lutea to confirm whether or not ovulation
had already taken place at the time of laparoscopy. The
notebooks record that laparoscopy was carried out on days
10–12, with an initial interval between HCG and laparoscopy of
28.75–29.50 h, increased to 29.50–30.00 h from mid-January
1970, and then to 32.0–33.5 h in mid-March 1970 (See Table 2
and Suppl. Table in Elder and Johnson, 2015b). This interval was
adjusted for natural cycles during 1978, when the timing of the
laparoscopy was set at 15–35 h after detecting the LH surge
(Edwards et al., 1980a, p.748 and Table IV). Eggs recovered are
described as ‘fixed’ prior to October 1969, and are presumably
those that were studied cytologically and/or chromosomally
with many not fully mature at recovery (Elder and Johnson,
2015b, Steptoe and Edwards, 1970).
Follicle stimulation regimes
Two important initial goals were to aspirate oocytes from
their follicles just before ovulation was expected, and to
have more than one pre-ovulatory oocyte for aspiration.
Injection of the gonadotrophic hormones, human menopaus-
al gonadotrophin (HMG) and HCG, was felt to be necessary in
order to control the menstrual cycle and regulate follicle
growth, oocyte maturation and ovulation (Edwards et al.,
1980a, 1980b; Steptoe and Edwards, 1970). Table 2 shows
the variations over the years in the stimulation regime used
to induce follicular maturation, described in Steptoe and
Edwards (1970) as “a priming dose of HMG, followed by an
ovulatory dose of HCG”. In the absence of any knowledge
about the potential ovarian response, and in order to avoid
the risk of ovarian hyperstimulation syndrome, low doses
Figure 1 Photograph of “suction device”: a simple aspirator for withdrawing the contents of human follicles. A vacuum applied at
the wide arm (E) is directed through the needle when required by simply blocking the open Y-arm (B) in the aspirator. Oocytes and
follicular fluid are withdrawn through the needle (F) and its lead (D) into the collecting chamber (A). The collecting chamber can be
easily removed from the neoprene bung (C) and replaced (Edwards and Steptoe, 1975).
21The Oldham Notebooks III. Variations in procedureswere used initially. In 1969 injections of two ampoules of
HMG (Pergonal, G.D Searle and Co.) were given once or
twice only, starting early in the menstrual cycle (although
not always on the same cycle day, “because of the limited
times when laparoscopy could be done” (Steptoe and
Edwards, 1970). By the end of the year this had been
increased to three or four ampoules given in three doses on
alternate days, usually days 6, 8 and 10 of the cycle. Thus,
from July 1969, the dose was increased to three alternating
with two ampoules, and then to three or four doses of three
ampoules. The data comparing stimulation regime, follicular
size, number of oocytes retrieved and oocyte classification
was described in detail in Steptoe and Edwards (1970, Tables
I, II, III, IV, and V); that paper also mentions that
improvements seen were “probably due to improved tech-
nique”. It was further observed that “lower doses of
gonadotropin seemed to interfere with the cycle and extend
the interval to menstruation, whereas higher doses in
repeated injections appeared to dominate the natural cycle,
and impose an induced cycle”. However, they also speculated
that ”increasing doses of HMG could cause excessive secretion
of oestrogen and perhaps induce premature release of LH and
early ovulation”. During 1970, the dose was again increased to
four ampoules, and then again during 1972 to five ampoules,
three or four doses administered on alternate days (Table 2;
confirmed in Edwards et al., 1972, published in September).
Having observed that high levels of oestrogen in the
follicular phase were unfavourable for the luteal phase
endometrium (Edwards et al., 1980b), attempts were made
at the beginning of 1973 to modulate the effects of high
oestrogen levels by replacing Pergonal stimulation with
either clomiphene-stimulated cycles or natural cycles + HCGto induce follicular maturation. Between January and June
of that year, 17 patients were stimulated with 50 mg twice
daily of clomiphene citrate (Table 2; Clomid; supplier name not
found, but is recorded as being from Merrill-National Labora-
tories in Steptoe et al., 1986); for six of these patients (L361–
366, P 114, 128, 110, 129, 120, 130), cycles were converted to
timed intercourse without laparoscopy, presumably because
urinary oestrogens failed to reach adequate concentrations.
Five of the other 10 Clomid cycles [P121(1), 127, 368, 371,
121(2)] resulted in no eggs being retrieved after laparoscopy,
and the other five [P38(3), 125(1), 114(2), 110(2), 131(1)] had
only one or two eggs. Non-induced (natural) cycles (NC) are
mentioned in December 1973 (Table 2)with the addition of HCG
or Pregnyl (Organon) to induce follicular maturation: in six of
the nine cycles in December, no eggs were retrieved after
laparoscopy. During 1974, NC + Pregnyl or LH was used, in 25
and two cases respectively; of the 40 scheduled cycles
(Table 2), two were cancelled and in only three did oocyte
retrieval fail. We speculate that this improvement, which
continued in the six cases in 1975, may have been due to
experience gained with the repeated monitoring of cycles and
improving skill in follicular oocyte aspiration that was carried
out during this period (see section on monitoring, below).
Pergonal-stimulated cycles were also continued during
1973/74 (Table 2), and only Pergonal-stimulated cycles were
used from mid-1975 until October 1977, three or four doses of
five ampoules on alternate days in the majority of cases;
occasionally five ampoules were given as a first dose, followed
by two doses of two ampoules each ('5,2,2' regime). Many
patients were found to have high serum levels of prolactin (Prl)
after Pergonal/HCG administration (Edwards et al., 1980b),
and, between February and July 1977, 1.25–2.50 mg
Table 2 Stimulation and monitoring of treatment cycles by year.
Year Cycles (n)
(stimulated or
monitored)
Stimulation protocol
(Pn x doses)
IU of HCG (Hours
between HCG and
LOR) [Day of LOR]
Urine monitoring
1969 58 P2 x 1 or 2; then from July P3/P2 on
alternate days; then P3 x 4 or x 3
3000–12,000; 5000
from Sept
(28.75–29.50)
[D10–12]
24-h TE, alternate days from D6 –
D8 + occasional PD
1970 62 P4 x 3 5000 (Jan–Feb:
29.5–30.0;
Mar–Dec: 32.0–
33.5) [D10–D12]
24-h TE + PD, every 2 days + luteal
phase in some case. Results plotted
on graphs
1971 41 P4 x 3 5000 (33.5–36.0) 24-h urines: TE, PD, every 3 – 4 days
approx + PT in March/April
1972 41 P4 x 3, P3 x 4, P5 x 3, P5, P2 P2 5000, 8000 in Sept
(31.0–33.5)
24-h urines – TE, PD every 2 days + post–Lap
1973 44 P3 x 4, P2 x 4 (18 cases) CL/Pregnyl
(17 cases); NC/Pregnyl (9 cases)
5000 (3) 8000 (15)
5000 (2) 10,000 (2)
8000 (13) 5000
(32.5–33.0)
24-h urines: TE, PD every 2 days, + post–Lap
CL cases – daily from March onwards,
LH and FSH from March
1974 37 + 3C NC + Pregnyl (25 cases); NC + MRC
LH (2 cases); P3 x 4 or P4 x 3 (11 cases)
5000 (32.5–33.0) Daily 24-h urines –TE, PD, LH
1975 36 NC + Pregnyl (6 cases) P3 x 4 or P4 x 3
(30 cases)
5000 (NR) Daily 24-h urines: TE, PD, LH – + PT
from August
1976 55 + 1 c P4 x 4, P5 x 3, P5 x 4, P5, P2, P2 5000, 3000
(7 cases) (32 where
recorded)
Daily 24-h TE, PD, LH, + luteal phase
1977 43 P5 x 3+ Parlodel; CL/HMG (2 ),
NC/Hi-Gonavis (3 )
5000 2 cases MRC
LH (32–33)
24-h urines: TE, PD, LH + luteal
phase. From Nov: Hi-Gonavis
1978 78 + 2 c NC/Hi-Gonavis (78) [+P5 x 4 in 2 cases
for sterilization]
5000 Daily 24-h E, PD, LH; 3-h LH from
D5 – D7 until surge detected
Total 495 + 6 c – – –
AI = artificial insemination; CL = Clomid; D = day; TE = total estrogen; FSH = follicle-stimulating hormone; HCG = human chorionic gonadotrophin; HMG = human menopausal
gonadotropin; ITI = intra-tubal insemination; Lap = laparoscopy; LOR = laparoscopic oocyte retrieval; NC = natural cycle ; NR = not recorded; TE = total estrogen; Pn = number of
Pergonal ampoules; P = progesterone; PD = pregnandiol ; Prl = prolactin; PT = pregnanetriol.
a See Table 3 (Elder and Johnson, 2015b).
b See Table 4 (Elder and Johnson, 2015b).
c Cases for laparoscopic sterilization (see Table 1, Elder and Johnson, 2015b).
22 K Elder, MH Johnsonbromocryptine (Parlodel) daily was added from the
mid-follicular phase and throughout the luteal phase. Two
cycles were stimulated with clomiphene/Pergonal in the
second half of 1977. Then, apart from two patients for
laparoscopic sterilization who were stimulated with Pergonal,
all subsequent cases in the final series of 81 cases from
November 1977 to July 1978 were carried out in natural cycles
with detailed monitoring to detect the LH surge (see below).
The effect of these changes in stimulation regime on the
number of eggs retrieved can be seen in Table 2. The
percentage of cycles with successful egg recovery increased
from 83% to 95% by 1972, with a maximum of 11 or 12 eggs in
some cycles. The percentage of successful LOR dropped
during 1973 and the first half of 1974, with the use of
clomiphene and natural cycles, and then increased again
with re-introduction of HMG stimulation in 1975 (92%,
maximum seven eggs) and 1976 (80%, maximum nine eggs).
These various changes were attempts to retain control over
ovulation whilst not prejudicing the luteal endometriumagainst implantation. However, the failure to establish an
ongoing pregnancy prompted an alternative approach
towards the end of 1977, avoiding the use of exogenous
hormones altogether and thereby the accompanying adverse
effects on oestrogen levels and the luteal phase. This
re-introduction of natural cycles in parallel with more
detailed endocrine monitoring meant a reduction in the
numbers of successful LOR and eggs to 65–68%, but with
better overall success in retrieving competent preovulatory
oocytes for successful IVF (Edwards et al., 1980b).Endocrine monitoring: urines
See Table 2. In 1969, urinary total oestrogen (TE) in 24-hour
samples was estimated only once at first, and then on
alternate days after initiation of HMG therapy to assess
follicular maturation: “we were unable to do a detailed
analysis of urinary steroids for each day of the treatment
Serum monitoring Cancelled
LOR a (n)
LOR converted to
ITI/AI b or outcome
unrecorded (n)
LOR with documented
egg recovery (n) (% of
stimulated cycles started)
Eggs (n) Mean no. of
eggs/cycle
(range)
NR None None 48 (83) 136 2.3 (1–8)
NR None 3 55 (89) 274 5.0 (1–12)
NR None 1 36 (88) 175 4.9 (1–12)
July: occasional Lap-day TE, Prl; April–
June: Blood groups, both partners
1 None 39 (95) 187 4.8 (1–11)
Occasional single TE, FSH, LH, Prl
(not all cases, not all tests)
6 12 25 (57) 86 3.4 (1–8)
Occasional single TE, FSH, LH, Prl
(not all cases, not all tests)
2 None 28 + 2 c (75) 85 + 4 c 2.9 (1–6)
HCG from Lap day in Sept. Occasional
luteal + Prl, LH from Sept.
2 None 33 (92) 117 3.5 (1–7)
From Sept: E, FSH, P, Prl, 1–6
samples per cycle (not all cases,
not all tests)
4 3 ovaries not accessible
(P212, 224, 232)
44 + 1 c (80) 147 + 2C 3.3 (1–9)
Every 2–3 days: E, P, FSH, LH,
HCG, Prl
10 None 28 (65) 97 3.5 (1–9)
E, P, LH, FSH, Prl every
2 days + post-ET
13 2 ovaries not accessible
(P232, 213)
52 + 2 c (68) 57 + 4 c 1.2 (1–2)
– 38 22 388 + 5 c (78) 1371 3.6 (1–12)
23The Oldham Notebooks III. Variations in procedurescycle” (Steptoe and Edwards, 1970). Pregnanediol (PD), a
product of progesterone (P) metabolism, was also measured in
the last sample collected in some cases. From 1970 onwards,
both TE and PD were measured in all follicular-phase samples,
and occasionally throughout the luteal phase, in the latter
cases as a means to assess the luteal state. Estimation of a
second metabolic product of progesterone, Pregnanetriol
(PT), which was routinely assayed in at-risk pregnancies
during the 1960s, was added in March/April of 1973, but was
discontinued soon thereafter. LH and FSH were assayed from
March 1973, and, from 1974 onwards, the 24-hour urine TE,
PD and LH assays were carried out daily from just before or
just after the first injection of HMG, as well as daily after
laparoscopy, and then every second or third day towards
the end of the luteal phase, so as to monitor the effect of
follicular phase stimulation and egg retrieval on the luteal
phase. Urinary HCGwas also monitored after embryo transfer,
in order to detect potential implantation of an embryo
(‘biochemical pregnancy’).
Monitoring of the follicular phase in order to detect the
onset of the LH surge in natural cycles was introduced in
November 1977, using samples of urine collected every three
hours (RGE1, 1978). Every third or fourth sample was tested
to provide a baseline concentration, and as soon as anelevation was detected, several successive samples were
tested in order to confirm whether the surge had begun. LH
was monitored via the Hi-Gonavis Kit (Mochida Pharmaceu-
ticals). Collection of 3-hourly urines was discontinued after
laparoscopy, and the luteal phase was monitored via daily
24-hour urinary TE, PD and LH assays.Endocrine monitoring: serum
See Table 2. By the beginning of 1970, it was acknowledged
that, for later stages of the work, a correct hormonal
background would be required for tubal transport and implan-
tation before a pregnancy could be established (Steptoe
and Edwards, 1970). Only urine data was used initially, rather
than more valuable plasma data, because the latter “would
have imposed repeated trauma on our patients” (Edwards and
Steptoe, 1974, p.30). The first records of serum monitoring
appear in July 1972, with occasional assays for TE/FSH/LH/
Prl. Occasional blood sampling was continued during 1973
and 1974; from September 1975, serum HCG was monitored
after laparoscopy, and luteal Prl/LH tested in occasional
samples. Blood samples were taken more regularly during
1976: combinations of TE, FSH, P, Prl were tested in one to six
Table 3 Monitored cycles for 96 patients (L358 – 472)
between April 1973 and December 1975. (a) All 96 patients; (b)
A subset of 27 of the 96 patients with no record of laparoscopic
oocyte recovery (Oct 1973 – Aug 1974 + 1 Feb 1975).
(a)
Type of cycle Date Patients (n) Cycles (n)
CTI April – July 1973 16 a 18
NC + HCG July 1973 – Dec 1975 12 b 17
NC Oct 1973 – Aug 1974,
and Feb – Dec 1975
90 c 117
All types in
toto
April 1973 – Dec 1975 96 d 152
Type of cycle Patients (n) Cycles (n)
CTI 2 e 2
NC + Pregnyl 2 f 3
NC 25 30
All types in toto 27 35
CTI = Clomid + timed intercourse
LOR = laparoscopic oocyte recovery
NC + HCG = natural cycle with Pregnyl to induce ovulation
NC = natural cycle only.
a5 Five patients had only one CTI cycle, and no further monitoring or treatment.
b7 Seven patients also in CTI group.
c11 Eleven patients also included in CTI group.
d69 Sixty-nine of these patients were also prepared for LOR either at the same time,
or in previous or subsequent cycles.
e One patient had 1 CTI + 1 NC; the other patient had 1 CTI.
f One patient had 1 NC + HCG + two NC; the other patient had 2 NC + HCG.
24 K Elder, MH Johnsonsamples per cycle before and/or after LOR (not all tests,
not all cycles). In 1977 and 1978 blood samples were taken
every 2 or 3 days during natural cycles and analysed for
TE, P, FSH, LH, Prl, with the addition of HCG testing
post-embryo transfer. Between April and June 1972, blood
groups are recorded for each partner, possibly reflecting
Edwards’ interests in immunological causes of infertility
(Edwards, 1968a, 1968b, 1972, 1973; Gardner et al.,
1973).
Endocrine monitoring: follicular fluid
Samples of fluid from individual aspirated follicles (FF) were
collected throughout, from September 1969 to February
1978. Some FF samples were used for culture of oocytes in
1969; steroid assays (TE, P) were used to gain information
about the health and developmental stage of the follicles in
response to gonadotropin stimulation, and whether follicles
were atretic or pre-ovulatory (Edwards et al., 1980b;
Steptoe and Edwards, 1970). This information, in combina-
tion with the results of detailed endocrine monitoring and
outcome of IVF, formed the basis for the numerous papers
published between 1972 and 1978 (Edwards, 1973, 1974;
Edwards and Steptoe, 1975; Edwards et al., 1972, 1977,
1980b; Fowler et al., 1977, 1978a,b,c). Thus, in Edwards et
al. (1972, September), observations on follicles from 68
patients were described. Records show that both FF and eggs
were collected from 27 patients in 1969, 55 patients in 1970,
39 patients in 1971, and 36 patients to the end of July 1972,
a total of 157. Given that the stimulation regime used in this
paper was only settled on in 1970, this leaves a maximum of
130 patients, and since data from only those patients with
three or more follicles were reported, this number reduces
to (33 + 32 + 26 =) 91. Moreover, only one-third of FF
samples were described as being ‘clean’ of blood, so it
seems likely that the 68 patients in that study were drawn
from this group of 91. In that paper, FF from six follicles
taken from ‘some’ naturally cycling patients are described in
addition; these may be the three patients described in
August and September of 1971 (L290/P100, 291/P101 and
301/P106; Suppl. data 2 in Elder and Johnson, 2015b), but
we have found little information on these cases in the
notebooks. In a paper published 2 years later, Edwards and
Steptoe (1974) describe the effects of increasing the interval
between the first HMG and HCG injections and conclude that
ovulation prior to laparoscopy did not occur if the duration
of follicular stimulation before HCG injection did not exceed
9 days. Some of these data are tabulated and summarized
towards the end of notebook L0, and show that egg recovery
is lowest when the period from first HMG to HCG injection
was extended to 9 or 10 days.
Combined endocrine monitoring
Notebooks H3 and H4 reveal that a major effort was invested
in endocrine monitoring alone, separate from LOR cycles,
during the periods April 1973 – 10 February 1974 (H3) and
19 February 1974 – 22 June 1976 (H4). Thus, daily 24-hour
urine samples were collected from approximately day 5 or 6
of the cycle, continuing for several days into the luteal
phase, and were assayed for TE, PD and LH. Occasional bloodsamples were tested for TE, PD, Prl and FSH. There are no
records of LOR for parts of this period (e.g. 8 August to 6
December 1973, and 9 June 1974 to 16 March 1975), and so it
seems that this period was used to gain additional informa-
tion about the endocrinology of individual patient menstrual
cycles. A total of 96 patients were monitored in 152 cycles
of three different types, many of the patients monitored
through several cycles (see Table 3): (i) Clomid with timed
intercourse (CTI): 16 patients, 18 cycles; (ii) natural
cycles with Pregnyl (NC + HCG): 12 patients, 17 cycles;
(iii) natural cycles (NC): 90 patients, 117 cycles. Most
natural cycles were monitored between October 1973 and
August 1974 (108 cycles), the remaining nine being spread
between February and December 1975. Some of the
monitored Clomid and NC + HCG cycles led to laparoscopy
attempts in that cycle, and the LOR details for these are
included in the data for 1973 and 1974 (Table 2).
Twenty-seven of the 96 patients monitored through
35 cycles during this period have no record of any
laparoscopy, previously, contemporaneously or subse-
quently (and so are not represented in Suppl. Table,
Elder and Johnson, 2015b or elsewhere in these papers
other than in Table 3). The remaining 69 patients have
records of one or more LOR cycles, some of which were
carried out during 1973–1975, or before or after this
period.
Luteal support
As early as 1970, Steptoe and Edwards (1970) had drawn
attention to possible problems of using ovulation induction and
25The Oldham Notebooks III. Variations in proceduresfollicle aspiration for subsequent embryo transfer and implan-
tation. A shortened luteal phasewas noticed after gonadotropin
administration, and this was investigated by measuring urinary
levels of oestrogen and pregnanediol, whether or not embryo
transfer had been carried out (Edwards and Steptoe, 1974;
Edwards et al., 1980b). A significant inverse correlation was
found between follicular oestrogen levels and the duration of
the luteal phase, reflecting a situation similar to that reported
in the rabbit to that reported in the rabbit (Beier, 1974). The
notebooks record that between March and August 1977, early
secretory phase endometrial biopsies were examined histolog-
ically for several patients, confirming that the histology of the
uterus was abnormal after gonadotropin stimulation, with
shortening of the luteal phase, as reported in Edwards et al.
(1980a), p.743: “…endometrial biopsies taken from patients
who did not have an embryo implanted indicated that the
histology of the uterus was abnormal...” The additional material
from the Edwards’ archive contains records of approximately 150
endometrial biopsies taken between 1969 and 1977, including
day-2 as well as secretory-phase biopsies (RGE2, 1976).
Attempts were therefore made to correct luteal deficien-
cy, first by modifying stimulation in an attempt to lower
oestrogen levels (see section on stimulation, above), and then
by providing exogenous luteal support. Luteal administration
of Pregnyl is first mentioned in October 1972, three or four
injections of up to 5000 IU. Both Pregnyl and intramuscularTable 4 Luteal-phase support.
Year LOR with documented
egg recovery a (n)
(% of stimulated
cycles started)
LOR in which ET recorded
(% of LOR with eggs recovered)
1969 48 (83) 0
1970 55 (89) 0
1971 36 (88) 1 (3)
1972 39 (95) 5 (13; +1 GIFT)
1973 25 (57) 7 (28; +5 GIFT)
1974 28 (75) 9 (32; +1 GIFT??)
1975 33 (92) 11 (33)
1976 44 (80) 27 (61)
1977 28 (65) 21 (75) [19 SC; 2 NC]
1978 52 (68) 31 (60)
Total 388 (78) 112 (29) [+6 (or 7?) GIFT = 30]
EPL = early pregnancy loss; ET = embryo transfer; GIFT = gamete intrafa
cycle; NR = not recorded; EE = Ethinyl Estradiol.
a Excluding cases for laparoscopic sterilization (no ET and no luteal supprogesterone arementioned as luteal support during 1973–74,
with the addition of Primolut depot (hydroxyprogesterone
hexanoate) in July 1975, along with occasional mention of
Ritodrine, Indocid, and Ethinyl Estradiol supplementation
(Table 4). Bromocriptine (Parlodel) was given in the follicular
and luteal phase to a number of patients in 1977, and three
patients were also given luteal Clomiphene in an attempt to
reduce high oestrogen levels. However, with the exception of
those patients given Primolut, none showed any sign of early
pregnancy. The administration of Primolut depot did delay the
onset of menstruation (Edwards and Steptoe, 1974), and eight
samples described as “uterine casts/decidual tissue/products
of conception” were sent for histological examination,
seven between June and October 1976, and one in July
1977. Handwritten histology reports relating to endometrial
biopsies for three of these eight patients were found (RGE2,
1976): all three indicate “decidual changes in stroma; no
embryonic or trophectoderm tissue”.
Sperm preparation and insemination
See Table 5. Details of sperm preparation and insemination
are recorded from October 1969 (L186). Seminal plasma was
removed from the semen sample by washing twice, ‘with
gentle centrifugation’ (Edwards et al., 1970, 1980a, 1980b),
and spermatozoa were suspended to a final concentration
between 8 × 105 ml−1 and 2 × 106 ml−1, depending on theLuteal support Pregnancies recorded (n) (% per
ET; % per LOR with
eggs recovered)
NR None
NR None
NR None
Pregnyl, 5000/3000 IU Sept
1972 (1 case only)
None
Pregnyl 1500/3000/
1000 + Progesterone i.m.
(11/73)
None
Ritodrine, Progesterone,
Pregnyl, Indocid
None
Primolut from June, then
Primolut + Indocid + EE Dec:
Progesterone + Pregnyl
1 ectopic (9; 3)
Indocid, Primolut,
Progesterone/EE or
combinations; Pregnyl in
Sept, Parlodel in Dec
1 × biochemical, 9 possible EPL
(37; 23)
Parlodel, EE, Pregnyl, Clomid
(none for NC) Progesterone
i.m., then PV (by tampon)
1 × ?EPL 1 × live birth (10; 7)
NR 2 × miscarriage 1 × live birth
(10; 6)
5 clinical (4; 1) [+11 possible
pre-clinical = 10; 3]
llopian transfer; LOR = laparoscopic oocyte retrieval; NC = natural
port).
Table 5 Culture conditions, 1969–1978.
Year LOR with
documented egg
recovery a (n)
(% of stimulated
cycles started)
Eggs
retrieved
(n)
Medium 1: flushing, egg wash, sperm
wash, fertilization
Medium 2: cleavage/embryo transfer Cycles with
insemination (n) (% of
LOR with egg recovery)
[eggs inseminated (n),
% of eggs recovered]
Cycles with embryos
reported (n) (% of LOR
with egg inseminated)
[bTotal embryos (n),
% of eggs inseminated]
1969 48 (83) 136 No records until Sept; M199, Barry’s
B + BSA or HSA; FF: 10%, 20%, 50%
Minitube culture, 5% CO2 in air; M199,
Hank’s+ FCS, BSA, HSA, 2.5%;
7 (15) [27, 20] 1 (14) [1, 4]
1970 55 (89) 274 Microdrop culture, 5% CO2 60% FF/Barry’s
B, ‘special B’ (high pH), + Na/K
Whittingham’s/Weymouth’s 1:1 , 15% FCS
TyrB +0.36% BSA, 1%BSA; + Pyr, lactate,
bicarb; Tyr B minus extra bicarb + Heparin
10 IU/ml; Whittingham’s + 20% FCS
Whittinghams + incr. Na/K; Ham’s
F10 + 0.36 g% BSA, or 20%, 40% FCS
M199 + pyr, lact, bicarb, BSA M199 + 10 %
FCS +5%PO4 + 100iuml bicarb; Ham’s
F12 + 20%FCS or 0.72% BSA +1x L-Glutamine
Reduced O2 in May; Aug: 20% human serum
51 (93) [272, 99] 25 (49) [36, 13; +3 × 2PN]
1971 36 (88) 175 Tyr + Na/K for sperm and fertilization,
+0.36% BSA; Tyr for eggs:minus extra
bicarb, + PO4 + Hep for flushing
Streptomycin added for sperm
Ham’s F10, F12, + 20%FCS (inactivated),
+5%, 10%, 20% HS 5% CO2 in air, 5 % O2/5 %
CO2/90 % N2 from September; Oldham vs
Cambridge water compared
36 (100) [175, 100] 13 (36) [18, 10 + 1 × 2?PN]
1972 39 (95) 187 No phenol red in Tyrode’s; TyrB ± bicarb,
BSA/FCS/HS + Pyr, Penicillin Stock
solutions made. Autoclaved BDH water; 5
% O2/5 % CO2/90 % N2
Ham’s F10 + L-Glutamine +20 % FCS + 5 %
HS; Sept: Ham’s F10 + 20% maternal serum
collected at beginning of laparoscopy
35 (90) [179, 96] 10 (29) [15, 8; + 6 × 2PN &
1 × Syngamy]
1973 25 (57) 86 New batches Pyr, BSA, BDH water in glass or
plastic bottles, SVT for different paraffins &
sera, FCS tested with HeLa & GC cultures
As previously – serum inactivated/not
inact., Maternal serum, Paternal serum;
F10 minus bicarb for ET
20 (80) [81, 95] 8 (40) [8, 10; 2 × 2PN, 3 ×
?2PN]
1974 28 (76) 85 As previously, SVT for different sources of
HSA; extra Ca & Mg added in June
As previously, new F10 for ET: no BSA or
bicarb
28 (100) [81, 95] 10 (36) [15,18; +1 × 2PN]
1975 33 (92) 117 As before, extra Ca, Mg, P; McCoy’s
modified w/bicarb September:
EBSS + glucose, BSA, Pyr, Pen. Several
SVTs for different batches of media, sera,
maternal serum Nov: Tyrode compared
with Hoppit’s by SVT Dec: non-autoclaved
water, EBSS + Pyr, 0.21% bicarb, BSA, HS,
F10 reinforced: + Ca, Mg, Glutamine,
bicarb. No bicarb for ET. Laparoscopy
plasma, inactivated serum. All tested with
SVT
33 (100) [117, 100] 15 (46) [17, 15; +1 × 2PN]
1976 44 (80) 147 Earle’s for flushing, Fert, Sperm wash +
Pyr, Pen, ± bicarb
Ham’s F10 + bicarb, glutamine, Pen. FF
assays, GC cultures, ‘serum new method’,
inactivated + not inactivated; F10 for
cleavage and ET. All checked for
osmolarity
44 (100) [149, 100] 29 (66) [42, 29]
1977 28 (65) 97 As 1976, Earles Fert & Hep Earle’s Alb, +
0.36% BSA. Osmometer checked with new
standards: all media adjusted to 279–273
As 1976, F10 ‘serum new method; FF
assays, GC cultures, serum not inactivated
27 (96) [95, 98] 22 (82) [20 SC; 2 NC][35,
37]
1978 52 (67) 57 As 1977 As 1977; FF assays, GC cultures 50 (96) [60, 98] 34 (68) [34, 57]
Total 388 (78) 1361 331 (85) [1237/1361,
91]
165 (51) [221/1237; 18]
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27The Oldham Notebooks III. Variations in proceduresquality of the sample. ‘Barry’s B’ medium was used initially,
with modifications to NaCl and KCl concentrations, based
upon Na+/K+ analysis of follicular fluid. In August 1970, sperm
wash medium is noted as ‘Tyr B 7.5 g/L NaCl, 0.39 g/L KCl,
pH 7.55 290 mOsm’. Streptomycin and BSA (0.36%) were
added in 1971; pH and osmolarity are recorded for every
batch of medium made, pH 7.55–7.6, 290–296 mOsm. During
1975, Earle’s BSS was introduced for sperm washing (Earles BSS
+0.1 g% glucose and 0.36 g% BSA + 0.11 g% Pyr + Penicillin),
and this formula continued to be used through 1976 and 1977.
Sperm quality details are almost all written in Edwards’ hand,
with no indication of sperm count numbers, and only ‘sketchy’
descriptions, usually restricted to better-than-average sam-
ples, e.g., "sperm excellent", "sperm going like a rocket" (see
Suppl. Table, Column W, in Elder and Johnson, 2015b).
In 1970, Edwards et al. (1970) reported that at the end of the
laparoscopy procedure, “the oocytes were suspended in
droplets consisting of fluid from their own follicle (when
available) and the medium being tested for fertilization. After
incubation for 1–4 h at 37° C the oocytes were washed through
two changes of the medium under test before being placed in
the suspensions of spermatozoa. Preovulatory oocytes would be
ready for fertilization… by 3–4 h after collection. Many oocytes
were obviously not preovulatory, and therefore unsuitable for
fertilization, but all were placed in the fertilization droplets in
order to simplify our procedure” (Edwards et al, 1970, p.1371).
The records then show that oocytes were inseminated soon
after the end of the laparoscopy (see Suppl. Table, Column Q,
in Elder and Johnson, 2015b),washed two or three times in the
medium being tested for fertilization, and then transferred
into suspensions of spermatozoa in 0.05 ml microdrops under
oil (Brinster, 1963), at a concentration of 105 to 106 ml−1,
depending on the subjective assessment of sample motility
(Edwards et al., 1970). Time intervals between HCG admin-
istration and insemination are recorded from 1971–1975,
varying from 32.4 to 34.5 h after HCG. The cultures were
examined 3 h later, and the concentrations of spermatozoa
were sometimes reduced after cumulus dispersal was ob-
served, 4–6 h after insemination.Culture media
See Table 5. The notebooks reveal a major investment of
time and effort in trying to identify optimal conditions for
in-vitro culture. Their first successful attempts to achieve
fertilization and cleavage were described in Edwards et al.
(1970), which records the different types of media and
culture conditions that were tried: based on analysis of
follicular fluid electrolytes, Bavister’s medium was modified
by reducing NaCl and increasing KCl concentrations. Also
tried were Whittingham’s (unmodified), Waymouth’s and
Ham’s F10 with extra bicarbonate to raise the pH to 7.5–7.6,
supplemented with bovine serum albumin, with pyruvate
added to Waymouth’s. During this period, the embryos were
assessed for development/timing of cleavage divisions, and
analysed for cell number/mitoses after it was clear thatNotes to Table 5
ET = embryo transfer; FCS = fetal calf serum; FF = follicular fluid; LOR = laparoscopic oo
a Cases for laparoscopic sterilization not included.development had ceased, approximately 48 h after the last
division was observed. Although results of fertilization and
cleavage using the different media are reported in Edwards
et al. (1970), this paper also states “firm conclusions about
the value of different media obviously cannot be drawn
when so few ova were available”.
The notebooks reveal that during 1969, oocytes were
cultured in follicular fluid diluted 1:1 or 1:2 with Tyrode B.
M199 and Hank’s are also mentioned, as well as addition of
bicarbonate and bovine or human serum albumin. TE was
measured in the follicular fluid of eggs that were inseminat-
ed. Five inseminated eggs were transferred to live rabbit
oviducts in December, but no embryo development was seen
after recovering the eggs the following day. In March 1970,
three fertilized eggs were transferred to live rabbit oviducts,
with the same result, eggs recovered as "1-cell”. "Minitubes"
were used initially for embryo culture, microdroplets under
oil being mentioned first in January 1970. An atmosphere of
5% CO2 in air was obtained by placing culture dishes inside a
gas-filled desiccator, with various gas mixtures for culture
being tried: "reduced O2", 5 % CO2, 5 % O2/5 % CO2/90 % N2.
Notebook H0 contains flame photometry and osmolarity
records during 1970, with mention of Tyrode B, Tyrode C,
Ham’s F10 and F12, M16, M199, Whittingham’s, Whitten,
Weymouth, Hank’s-with or without pyruvate, lactate, bicar-
bonate, heparin, citrate, NaCl, KCl, as well as fetal calf
serum (FCS), or bovine serum albumin (BSA) in concentra-
tions varying from 0.5 to 50% (see Edwards et al., 1970).
Maternal serum (MS) was introduced for some cases in August
1970, and continued in use in varying concentrations
thereafter. Paternal serum was also added for a few cases
in 1972–73, as well as seminal plasma for two cases in 1974.
The osmolarity of human FF samples is also recorded, and all
batches of media were checked for pH and osmolarity,
because of the idea that FF might be involved in sperm
capacitation (see Edwards, 1974, p. 211). Whenever possi-
ble, the eggs from a single patient were divided between two
or three different types of media and/or serum concentra-
tions in an attempt to compare different culture media, type
and concentration of sera. Heparin was added to media used
for flushing follicles, and Penicillin added to egg wash
media. By November 1970, a system apparently evolved
(see Edwards et al., 1970) whereby different types of media
were used for each stage, with varying amounts of BSA, HSA,
FCS and/or MS:
Fertilization: TyrB + NaCl + KCL, pH 7.55, 295 mOsm + BSA
Sperm wash: same, pH 7.6
Egg wash: minus extra bicarb, + PO4 buffer, + 100 IU/l
Pen, pH 7.3, 290 mOsm
Flushing: as egg wash, +10 IU/ml Heparin, pH 7.3
290 mOsm
Cleavage: Ham’s F10, F12, +20 % FCS or 0.72 % BSA +1 ×
L-glutamine
Between 1971 and 1975, Tyr B was also then supplement-
ed with NaCl, KCl, MgCl2, CaCl2, PO4, glucose, pyruvate, incyte recovery; NC = natural cycle; SC = stimulated cycle.
28 K Elder, MH Johnsonvarying concentrations. Ham’s F10 was supplemented with
varying concentrations of L-glutamine, as well as extra Ca
and Mg. From 1974, bicarbonate was removed from media
for embryo transfer. Media pH was measured as being
between 7.3 and 7.6, and osmolarity was gradually reduced,
from a range of 293–310 in 1972 to 285–287 (1973), 280–283
(1974) and 279–284 thereafter. Although the rationale
behind these various changes is not recorded in the data
available to us, the modifications were evidently aimed
towards achieving the osmolarity found in FF (Edwards,
1974), presumptively providing optimal conditions for
fertilization and embryo culture. Further correspondence
in archive material (RGE3, undated) contains several
handwritten undated sheets with media recipes, including
one note that indicates consultation with J Paul (Dr John
Paul, Beatson Institute, Glasgow), the recognized authority
on tissue culture at that time. This collection of papers also
contains correspondence during 1970–71 with Flow Labora-
tories about the exact composition of F10/F12 and gluta-
mine supplementation, with Hoechst regarding the purity of
BSA, with BDH regarding the composition of their gelatin
preparation, and with Millipore regarding the wetting agent
used in their filters (RGE4, 1970). All of this correspondence
emphasized their concern about possible toxicity in the
choice of materials used for culture of human tissue cells.
During 1972 and 1973, comparisons were made between
media made with Oldham versus Cambridge water and media
made with BDH water when made up in chromic-acid washed
glass versus plastic flasks. Different sources of BSA and FCS
were compared, as well as different methods of preparing
maternal serum (inactivated versus not inactivated). Sodium
and potassium levels in serum and follicular fluid were
measured by flame photometry, and the osmolarity of 15
different samples of maternal serum was checked. Stock salt
solutions were made up for media preparation, with different
‘recipes’ for the various types of media. ‘Heavy’ and ‘light’
paraffin were tested in sperm viability assays, and different
concentrations of FCS were tested for their effects on cell
count and morphology in HeLa and granulosa cell cultures.
Earle’s balanced salt solution (EBSS) was introduced in
September 1975, and numerous tests and comparisons were
made using different batches of serum and paraffin, as well
as differing concentrations of bicarbonate, all with osmo-
larity/pH checks and sperm viability assays. By June 1976,
recipes for five different media are listed, and these
remained (more or less) constant, with new batches made
every 2–3 weeks until the records end in July 1978 (Suppl.
Table). Varying concentrations of FCS, HSA and/or maternal
serum were also added to the media before use, settling on
7.5% for sperm/egg wash and fertilization, and 15% human
serum for ‘cleavage media’ by 1977.
Table 5 indicates key changes in the culture system in
relation to the number of cases with successful culture of
embryos/embryo transfer. The first sign of successful
fertilization is described in November 1969 (L190/P9), and
cleaved embryos were first seen in January 1970 (L200/P50),
after collecting eight eggs: sperm samples were washed in
‘Barry’s B’, then ‘some of Barry’s Special B’ added 2 h later.
The eggs were split into two groups, four transferred to
Whittingham’s, and four kept in ‘Barry’s B’; 4-cell embryos
were observed in both media, and were fixed in formalin.
The first blastocysts are described in August 1970 (L247/P42), after transferring inseminated eggs to Ham’s F10
containing 20% inactivated human serum. As described in
Steptoe et al. (1971) and in Edwards and Steptoe (1980),
these blastocysts were fixed and stained for chromosomal
analysis. The first embryo transfer procedure was attempted
16 months later in December 1971 (L303/P75). The first
pregnancy, in June 1975 (Steptoe and Edwards, 1976),
followed their twenty-fifth embryo transfer procedure,
42 months after the first embryo transfer (L446/P38).
Embryo freezing
During the summer of 1977, preliminary attempts were
made to cryopreserve a few embryos in the hope of
bypassing the adverse effects of stimulation on the luteal
phase uterus by transferring frozen-thawed embryos in a
subsequent natural cycle. However, the thawed embryos did
not continue to develop in vitro (Edwards and Steptoe,
1977), a failure that contributed to their next crucial
decision: to avoid the use of drugs completely and to
attempt to collect single pre-ovulatory eggs in natural cycles
monitored for the LH surge (Edwards and Steptoe, 1980,
p.132-135).
Embryo transfer
The first attempt at embryo transfer was in December 1971
(L303/P75), a 16-cell embryo 80 hours post-oocyte retrieval.
Although they recognized that evidence from bovine and
laboratory animals suggested that reimplantation via the
cervix could result in a low rate of implantation, this
route was chosen because “Passage through the cervix was
adopted as the method giving least trouble to the mother; a
fine catheter of 2.0 mm diameter was passed through the
cervical canal in the uterine cavity, and a smaller cannula
containing the embryo was threaded through it." (Edwards
and Steptoe, 1974, p.32). This paper recommends that
trans-cervical embryo transfer should be fully tested in
patients, in order to avoid a further surgical procedure to
gain access to the uterine cavity. Nothing in the notes
mentions the details of trans-cervical transfers, although
Edwards et al. (1980a) state that: “A bi-valve speculum was
passed with the patient in a modified lithotomy position … no
instruments were attached to the cervix… the loaded cannula
was passed through the cervix so that its end would lie in the
body of the uterus about 1 cm from the fundus …”. As
indicated in Table 4, injections of Ritodrine (Philps-Duphass)
or indomethacin were later given as a precaution against
uterine contractions after trans-cervical transfer. Of the 112
embryo transfer procedures carried out between 1971 and
1978, 106 were trans-cervical, four via laparoscopy (L412/
P158, April 1974, L604/P217, L607/P54, L608/P55, September
1976), one via intraperitoneal surgery (L430/P144, May 1974)
and one via mini-laparotomy (L704/P275, April 1978). A total of
six or seven gamete intra-fallopian transfer (GIFT) procedures
are also recorded between 1972 and 1974 (Elder and Johnson,
2015b).
It was widely believed at the time that that embryos had
to be transferred when they were at the 8- to 16-cell stage,
a belief based on two lines of evidence. The first came from
observations made on embryos flushed from the uteri of
naturally mated women, suggesting that embryos moved
into the uterus at these stages (Croxatto et al., 1972),
and the second from observations that earlier transfers
29The Oldham Notebooks III. Variations in procedureswere lethal for the embryos of animals (Marston et al., 1977;
Polge, 2000). Accordingly, the first five embryo transfers
carried out in 1972 were of embryos at the 8- to 16-cell
stage; however, during 1973, six of the seven embryo
transfers were of 5- to 6-cell-stage embryos on day 3,
and one embryo transfer of 8- to 12-cells on day 4. Between
1974 and 1976 embryos were transferred mainly at the
morula/blastocyst stage, on day 4/5, and in 1977–78
embryos were transferred at 8- to 16-cell stage, on the
evening of day2/morning of day3, or 8- to 16-cell morula
stage on day 4.
Genetic analysis of embryos
Evidence of Edwards’ continuing interest in developmental
genetics (Johnson, 2011) and in preimplantation genetic
diagnosis (PGD) in particular (Edwards and Gardner, 1968),
are found in 1970 with references in the notes to “Y bodies”:
Lap248 (blastocyst – negative) and Lap249 (12–16 cell –
negative), and in 1971: Lap278 (early blastocyst – “at least
one Y body – photo”) and Lap279 (early blastocyst –“no Y
fluorescence”). The Y body had been described by Pearson
and Bobrow (1970) using quinacrine fluorescent dye to stain
interphase nuclei from males. References to Y bodies start
with the development of the first blastocysts, because
Melander (1962) had shown that sex chromatin could not be
detected in pre-blastocyst stage embryos, the nuclei at
earlier stages being too heterochromatic. Presumptively
that might also have prevented attempts at visualisation
of the Y body? References to Y bodies cease after embryo
transfer becomes the norm, reflecting the requirement to
fix and stain the embryos for their detection, which was no
longer possible.
General discussion
Table 6 summarises the data for each of the pregnancies
that are recorded: 11 potential pre-clinical pregnancies, one
ectopic, two miscarriages and two live births. Table 7
outlines a timeline of the critical events described here.
Four features stand out in this description of how Edwards,
Purdy and Steptoe attempted to move from IVF to a term
pregnancy. First, the scale of the problem, as summarized in
Table 1, was daunting. So much had to be worked out from
scratch.
Second, the transparency of the three workers is striking:
they published in minute detail the ways in which they were
attempting to overcome each problem, to the extent that
there is remarkably little information from the notebooks
that is not available already in the public domain. What is
also notable about this body of work is its thoroughness,
solidly based on an informed reading of the contemporary
literature, as exemplified by the comprehensive account by
Edwards (1974) of follicular fluid properties. In this regard,
the approach taken was ethically sound, a theme to which
we return in the next paper.
Third, the data reveal the extraordinary amount of work
involved in achieving the two live births: it is exhausting to
read how meticulously all the media were prepared and
tested; likewise, the hormonal assays required collection of
multiple samples of fluids followed by assay procedures andrecording and analysis of results. Much of this work was done
by Purdy, whose role in the whole enterprise is reassessed in
Johnson and Elder (2015b). Some of the research undertaken
was truly heroic – especially the 24-hour monitoring of
3-hourly urine samples for LH when natural cycles were
being used: all these had to be done on site, as rapid
feedback was required. The original Hi-Gonavis kit based on
haemagglutination was very unreliable (M. Macnamee,
personal communication), which may explain why some
natural cycle LH surges (11/78) were missed. It is less clear
to what extent the other hormonal assays were also done
in-house; however, the technology for any kind of endocrine
assays in those days was poor relative to today, giving less
reproducible results. A series of 39 hormone reports from GD
Searle Scientific Services (dated between 10 and 11
December 1969 and 9–10 March 1970; RGE5, 1969) indicates
that assays for urinary TE and Pwere sent off initially to be done
commercially (confirmed in Edwards et al., 1972), but lab
results found in the Edwards’ archive show that during 1975
assays were carried out at ODGH (RGE6, 1975). The analysis of
aspirated follicle fluids (FF) for steroid content (TE, P) was
certainly done in-house by radioimmunoassay (although initially
by a protein binding assay for progestins). These in-house assays
were done in Cambridge eventually, but initially in collabora-
tion with Abrahams in Los Angeles and with Fotherby at the
Hammersmith Hospital, London (Abrahams et al., 1970;
Edwards et al., 1972), and were used to gain information
about the health and development of the follicles in response to
gonadotropin stimulation. This information, in combination
with the results of detailed endocrine monitoring of urine (and
later blood) and the outcome of IVF, formed the basis for the
numerous papers published between 1972 and 1980 (Edwards,
1973, 1974; Edwards and Steptoe, 1975; Edwards et al., 1972,
1977, 1980a, 1980b; Fowler et al., 1977, 1978a,b,c; Younglai et
al., 1972).
Fourth, whilst our account describes their attempts at a
rationally derived and methodically scientific approach to
overcome the many problems encountered, it is difficult to
conclude that any specific variation in treatment tried had any
impact on whether a sustainable pregnancy was achieved.
This conclusion contrasts with the ways in which the earlier
events in the sequence of problems (such as optimizing the
stimulation regime to maximize egg recovery) were solved
methodically and rationally. Such a contrasting conclusion
is not surprising, as, whilst the earliest challenges in the
sequence have direct and measurable outcomes, the ultimate
challenge of a live birth after embryo transfer involved several
factors, as outlined and discussed in Edwards et al., 1980a,
p.752-754), in particular: “attention must obviously be given
to the methods used for placing embryos, and to the uterine
physiology at the moment of implantation … the placement of
embryos is not necessarily the weakest point in our technique.
The embryos implanted only when all of the sequences had
been successfully accomplished – aspiration, fertilization and
cleavage included…”. He there identified the important
features in the sequence, i.e. (i) transfer technique, (ii)
timing and numbers of embryos transferred, (iii) embryo
quality, and (iv) endometrial receptivity. The third and fourth
of these factors remain problematic today, and then, as now,
there were strong reasons to believe that achieving the first
might prejudice the second. Given that the challenge of
post-transfer failure occupied the three researchers for 7 of
Table 6 Summary of data for all potential pregnancies recorded.
Date (ET
number)
L number/P
number
Age of
patient
(years)
Stimulation
protocol
Culture media Embryo details Luteal support Outcome (date)
June 1975 (25) L446/P38 35 P4 x 3 Tyr B, Tyr B reinforced, F10
reinforced, 15% HS
Morula, D4 Primolut depot + oral Primolut Cornual ectopic
June 1976 (38) L484/P202 27 P5 x 3 F10+ extra Ca/Mg, Earles/7.5%
HS, then F10 15% HS
2 blastocysts Pregny/Indocid/Progesterone,
+Primolut depot
?Early pregnancy loss (16 Jul)
June 1976 (41) L488/P204 25 P5 x 3 F10/7.5% HS, then F10 15% HS 1 morula, 1 blastocyst Pregny/Indocid Primolut depot ?Early pregnancy loss (16 Jul)
June 1976 (43) L491/P185 34 P5 x 3 “Serum new method”, Earles/7.5%
HS, then F10 15% HS
32-cell, D5 Pregnyl/Indocid/Progesterone Passed tissue. ?Foetal tissue
present.
June 1976 (45) L494/P188 27 P5 x 3 Earles/7.5% HS, then F10 15% HS Early blastocyst, D5 Pregny/Indocid Progesterone Curettage (10 Sept). ?Retained
products
July 1976 (48) L498/P211 31 P5 x 4 Earles/7.5% HS, then F10 15% HS Morula, D4 Pregnyl/Primolut ?Passed material (17 Jul)
July 1976 (49) L500/P131 30 P5 x 3 Earles/7.5% HS, then F10 15% HS Blastocyst, D5 Pregny/Primolut/EE ?Decidual cast (19 Aug)
July 1976 (50) L501/P213 27 P5 x 3 Earles/7.5% HS, then F10 15% HS Blastocyst, D5 Pregny/Primolut/EE ?Large piece of material (24
Aug)
Sept 1976 (54) L607/P28 40 P5 x 4 Inact. serum, FF; F10/15% HS Morula/blastocyst, via
lap, D4
Pregnyl/Primolut Uterine casts/decidua/POC,
histology negative
Sept 1976 (55) L608/P207 NR P5 x 3 Inact. serum,FF; Earle’s 7.5% HS,
then F10, 10%, then 15% HS
2 morula/early
blastocysts, via lap
Pregnyl/Primolut Uterine casts/decidua/POC,
histology negative
Sept 1976 (56) L612/P199 35 P5 x 4 Inact. serum, FF F10 15% HS 8-cell, D3 Pregnyl/Primolut No Indocid Biochemical (HCG = 57),
histology negative
July 1977 (74) L659/P257 36 P5 x 3 Earles/7.5% HS, then F10 15% HS 2 embryos, D2 Primolut/Parlodel Tissue (5 Aug): decidua – no
chorionic villi
Nov 1977 (81) 666/P264 31 NC Earles/7.5% HS, then F10 15% HS 8-cell, D2 evening None Live birth (Jul 1978)
Jan 1978 (82) 673/P267 37 NC Earles/7.5% HS, then F10 15% HS 8-cell, D2 evening None 9/10-week gestational sac;
ERPOC (Mar)
May 1978 (97) 712/P247 31 NC Earles/7.5% HS, then F10 15% HS 8-cell, D2 evening None Live birth (Jan 1979)
July 1978 (109) 738/P265 31 NC 12–16-cell, D3 None Miscarried (26 Nov)
D = day; EE = ethinyl estradiol; ERPOC = evacuation of retained products of conception; ET = embryo transfer; HCG = human chorionic gonatotrophin; lap = laparoscopy; POC = products of
conception; Pn = number of ampoules of Pergonal.
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Table 7 Timeline of the critical events in dataset.
Event Date No. in series/Patient
number
L number
“New suction gadget” September 1969 43/P35 179
Insemination recorded October 1969 50/P42 186
Fertilization recorded November 1969 54/P9 190
“Excellent” embryos (8-cell, 4-cell) January 1970 64/P50 200
First blastocysts August and September 1970 111/P42, 247
112/P38, 248
117/P49 253
First embryo transfer December 1971 169/P75 303
Daily urinary monitoring March 1972 190/P71 324
First GIFT 26 April 1972 193/P114 327
Luteal support introduced October 1972 211/P107 345
Additional cycles monitored before LOR April 1973 to December 1975 N/A L358–472, + 26 patients
without L number
Regular sperm viability testing for media,
serum, oil etc
From July 1973 N/A N/A
Clomiphene or NC/HCG cycles January to June 1973,
December 1973
217–237/
P246–P256
351–371
380–390
First pregnancy June 1975 312/P38 446
Serum monitoring introduced September 1976 377/P28(9) 607
Hi-Gonavis for LH monitoring November 1977 438/P263 665
First live birth ET July 1977 439/P264 666
ET = embryo transfer; GIFT = gamete intrafallopian transfer; HCG = human chorionic gonadotrophin; LOR = laparascopic oocyte retrieval;
N/A = not applicable; NC = natural cycle.
31The Oldham Notebooks III. Variations in proceduresthe 9 years between achieving IVF and Louise Brown’s birth,
the approach to each of the four factors, identified above as
potential influences on the outcome, will be discussed briefly.
(i) Transfer technique: In the early 1970s, non-surgical
cervical transfer approaches in animals generally were
under-developed; indeed it was only some 40 years
later that such a technique was described for the mouse
(Green et al., 2009). Moreover what was known was
unpromising, as this route had been proving problematic
in cattle for some years, as Edwards was well aware
given that most of the research had been pioneered by
Rowson and Moor in Cambridge at the Institute for
Animal Reproduction (Polge, 2000). Eventually highly
successful, it took years of painstaking experiments to
perfect a simple reliable technique. It remains unclear
today why such a (now) routine procedure should have
proved so difficult to master, but one suggestion is that
operator skills are the most important variable in
achieving high pregnancy rates in cattle (Schneider
et al., 1980; Seidel et al., 1975). It seems likely that
Steptoe did most of the transfers, although Edwards
evidently did some himself (see Johnson and Elder,
2015b), but this information is not recorded in the
notes. Most of these transfers were trans-cervical, with
only 6/112 using Steptoe’s surgical skills. Following the
ectopic pregnancy in 1974, Steptoe insisted that all
women on the programme who had damaged tubes
should have their cornua sealed during the exploratory
laparoscopy that each underwent before being accept-
ed definitively on the programme (NF and JW, pp.5 and
30–31; in Suppl. Material 1 in Johnson and Elder,
2015a): a consequence of his fear of the possibleconsequences following transfer of embryos high in the
uterine fundus.
(ii) Timing and numbers of embryos transferred: whether or
not Edwards’ belief that the time of day was critical for
embryo transfer is correct, what seems likely is that
success might have come earlier had they been in a
position to transfer more than a maximum of two
embryos. However, rarely was this possibility available
to them, although on two occasions in 1977, three
embryos were transferred (L637 and L650). Edwards had
contemplated the consequences of multiple pregnan-
cies back in 1965 (Edwards, 1965), and was firmly of the
view that it was better to err on the side of caution,
again reflecting his concern for the patient’s welfare.
(iii) Embryo quality: this leads us to embryo quality
assessment, which then, as now, was achieved largely
by qualitative appearance and the division rate and
synchrony of embryonic blastomeres. More significant
than embryo quality, however, was quantity. Thus,
some of the changes to stimulatory regimes had adverse
effects on oocyte recovery or fertilisation rates (see
Tables 2 and 5), and with recourse to natural cycles,
only a single embryo was available. Ultimately, the
embryos that were being produced then were probably
no more the cause of their problems than they are
today.
(iv) Endometrial receptivity: from 1973, a major effort was
directed at either trying to reduce the adverse impact
of the ovarian stimulation injections on the luteal-phase
uterus or circumventing it in some way. Notably, during
the summer of 1977, preliminary attempts were made
to cryopreserve a few embryos in the hope of bypassing
the adverse effects of stimulation on the luteal-phase
32 K Elder, MH Johnsonuterus by transferring frozen-thawed embryos in a
subsequent natural cycle. This suggestion is, to our
knowledge, the first time this possibility was ever
raised, and it remains pertinent to discussions in clinical
IVF some 38 years later (Cohen and Alikani, 2013a).
However, the failure of this approach contributed to
their next crucial decision taken in November 1977:
to avoid the use of drugs completely and to attempt
to collect single pre-ovulatory eggs in natural cycles
monitored for the LH surge (Edwards and Steptoe, 1980,
p.132-135) – no mean task at that time, as the shocked
staff realised when told of the decision (NF, p.38, in
Johnson and Elder, 2015a, Suppl. Material 1). By the
time that the decision to use monitored natural cycles
was implemented, 437 LOR (84% of total) and 79 embryo
transfers (71% of total) had already been performed.
In conclusion, it is important to re-emphasize just how
little was known at the time about the areas of study in
which they were engaged, and how limited was their access
to helpful technology. What shines through is their persis-
tence in the face of constant failure. Whilst in no sense could
their approach be described as a double-blind controlled
trial, it was an empirical study, albeit soundly based on a
thorough reading and understanding of the literature – and
as such does not differ fundamentally from most comparable
research even today (Cohen and Alikani, 2013b). The
persistence of both their entire team and their patients
was based on trying to climb this steep ‘learning curve’ by
adapting and reacting to what was being learned. In the next
paper, we enquire more closely into the roles played by their
patients in this process.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.rbms.2015.04.004.Acknowledgements
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